ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

BACKGROUND: It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important regulator of lipid metabolism. In this study, we explored how ANGPTL3 impacts dyslipidemia during PNS development. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Fu, Liu, Shurao, Li, Yue, Li, Guanyu, Liu, Ming, Wang, Jingzhi, Cui, Weijing, Suo, Yanhong, Gao, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996604/
https://www.ncbi.nlm.nih.gov/pubmed/35399079
http://dx.doi.org/10.1186/s12944-022-01632-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996604/
https://www.ncbi.nlm.nih.gov/pubmed/35399079
http://dx.doi.org/10.1186/s12944-022-01632-y

Ejemplares similares